Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...
In the US, it is estimated that 8.5 million people are unaware that they have T2D, which can lead to serious health problems. A new research project addressed this...
The FDA announced that a new type 1 diabetes stem cell therapy from Vertex has been cleared to enter clinical trials in the United States. The therapy, which hopes to...
Researchers at the 2023 ATTD conference discussed the challenge of keeping up with insulin requirements in women with type 1 diabetes during pregnancy. After reviewing...
Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project to...
New study results showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by...
In recent years, researchers have increasingly looked to stem cell–based therapies as one strategy to find cures for chronic conditions like type 1 diabetes. But what...
diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM),...
The Type 1 Diabetes Index, a first-of-its-kind global database of people with type 1 diabetes, is a large registry of data designed to power critically important changes...
A U.S. clinical trial is recruiting adolescents between the ages of 12 and 18 with type 1 diabetes who are willing to add an SGLT2 inhibitor to their treatment regimen...
A U.S. clinical trial is recruiting adolescents and adults between the ages of 14 and 45 with recently diagnosed type 1 diabetes to evaluate the effectiveness of...
A U.S. clinical trial is recruiting children between the ages of 4 and 17 with type 1 or type 2 diabetes whose families are interested in having their children try...
A once-weekly insulin option would bring several benefits to people with type 1 diabetes. This study will evaluate the safety and glucose-lowering effect of an...
Metformin is the world’s most common diabetes medication and is often referred to as a miracle drug. However, use of metformin in those with chronic kidney disease (CKD...
A Bayer clinical trial is seeking to evaluate the safety and efficacy of finerenone, which treats chronic kidney disease, alongside empagliflozin, a type 2 diabetes drug...
About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...
Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...
A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...
The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept...
Researchers presented on the exciting weight loss efficacy of tirzepatide. While tirzepatide has not yet been approved for weight loss, the SURMOUNT clinical trial...

Pages